This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Toray Industries, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Marina Nogami: Innovator in Ferroptosis Research
Introduction
Marina Nogami is a prominent inventor based in Kamakura, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target ferroptosis, a form of regulated cell death.
Latest Patents
Marina Nogami holds a patent for a tetrahydroquinoline derivative and its medicinal use. This compound features a tetra-hydroquinoline skeleton and exhibits inhibitory action against ferroptosis. It has potential therapeutic or preventive effects on diseases related to ferroptosis inhibition, such as multiple sclerosis. The patent details a tetrahydroquinoline derivative represented by a specific formula or a pharmaceutically acceptable salt thereof.
Career Highlights
Marina is currently employed at Toray Industries, Inc., where she continues her research and development efforts. Her work focuses on innovative solutions in the field of medicinal chemistry, contributing to advancements in healthcare.
Collaborations
Marina collaborates with esteemed colleagues, including Takehiro Takahashi and Ken Nunettsu Asaba. Their combined expertise enhances the research and development initiatives at Toray Industries, Inc.
Conclusion
Marina Nogami is a trailblazer in the field of medicinal chemistry, with her innovative work on ferroptosis inhibitors paving the way for new therapeutic options. Her contributions are vital to advancing medical science and improving patient outcomes.